DRAFT TRANSLATION · REVIEW PENDING
INVESTMENT OUTLOOK
INVESTOR RELATIONS · HAEPAGEN
GROWTH & RETURN OUTLOOK
Investment return outlook driven by HAEPAGEN's growth
Investment Return Outlook Driven by HAEPAGEN's Growth
Cosmetic Ingredient Business Growth
Expanding revenue and building a stable profit structure
Shareholder Value Realization
Providing investment returns through a dividend policy
Pharmaceutical Ingredient Commercialization
Entering the high-value biomaterials market
Global Investment Attraction
Expanding overseas capital and strategic partnerships
Enterprise Value Growth and Investment Returns
Targeting an expected enterprise value of KRW 300–500 billion